empowering muscle
empowering lives

Discover muscle biology Rectangle

Welcome to AHA Scientific Sessions 2021

LEARNING STUDIO

11/14/21, Sunday at 9:30-10:15am ET

Implementing GDMT in Worsening Heart Failure Patients – Easy or Challenging?
A Debate

FOR MORE INFORMATION

AHA Scavanger Hunt

Download the AHA Conference app and scan here to earn points.
Download the AHA Conference
app and scan here to earn points.

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.

Visit our corporate site

Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function.

Request Information
Group 14

Contact Information

Medical Information Request

Now Entering Cytokinetics Pipeline

Group 14

This information is intended for healthcare providers only. Compounds are investigational.
Inclusion in this display does not imply regulatory approval for these compounds in any indication.
Information about all Cytokinetics-sponsored trials can be found at cytokinetics.com/clinical-trials/

Continue to Pipeline

Now Leaving the Virtual Exhibit

Group 14

You are now exiting the Cytokinetics exhibit for the AHA Scientific Sessions 2020 Virtual Meeting. The link you’ve selected will take you to an external website.

Continue Offsite